Emcure Pharmaceuticals Ltd Net Asset Momentum
Emcure Pharmaceuticals Ltd net asset momentum. Emcure Pharmaceuticals Ltd (EMCURE) recorded a net asset momentum of 7.2% as of March 2026, with net assets of Rs49.77 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Emcure Pharmaceuticals Ltd shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Emcure Pharmaceuticals Ltd (2022–2026)
Net asset momentum of Emcure Pharmaceuticals Ltd from 2022 to 2026. This chart tracks Emcure Pharmaceuticals Ltd's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +7.2%, with net assets of Rs49.77 Billion INR as of March 2026. Check Emcure Pharmaceuticals Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Emcure Pharmaceuticals Ltd Net Asset Momentum by Year (2022–2026)
Emcure Pharmaceuticals Ltd net asset momentum by year from 2022 to 2026. The table below shows the complete annual net asset history for Emcure Pharmaceuticals Ltd from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Emcure Pharmaceuticals Ltd stock valuation.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs49.77 Billion | Rs96.12 Billion | Rs46.36 Billion | ▲ +7.2% |
| 2025 | Rs46.42 Billion | Rs82.33 Billion | Rs35.91 Billion | ▲ +48.7% |
| 2024 | Rs31.22 Billion | Rs78.06 Billion | Rs46.84 Billion | ▲ +17.8% |
| 2023 | Rs26.50 Billion | Rs66.73 Billion | Rs40.23 Billion | ▲ +25.3% |
| 2022 | Rs21.14 Billion | Rs60.63 Billion | Rs39.49 Billion | — |